Americas (WHO region) vs Myanmar: Cases started on MDR-TB treatment
Americas (WHO region)
5,225
in 2024
Myanmar
2,478
in 2024
Americas (WHO region) rank
11th
Myanmar rank
13th
Cases started on MDR-TB treatment over time
- Americas (WHO region)
- Myanmar
How they compare
Americas (WHO region) currently reports 5,225 against 2,478 in Myanmar, a difference of 2,747.
That makes Americas (WHO region)'s figure about 2.1 times Myanmar's.
Across all 17 years both countries report, Americas (WHO region) has been ahead every year.
Americas (WHO region) ranks 11th and Myanmar ranks 13th of 11 groups.
Americas (WHO region) has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Americas (WHO region) | Myanmar | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 2,618 | 32 | 2,586 | Americas (WHO region) |
| 2010s | 3,609 | 1,595 | 2,013 | Americas (WHO region) |
| 2020s | 4,846 | 2,245 | 2,601 | Americas (WHO region) |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cases started on mdr-tb treatment, Americas (WHO region) or Myanmar?
- Americas (WHO region), at 5,225 against 2,478 in Myanmar as of 2024.
- What is the difference in cases started on mdr-tb treatment between Americas (WHO region) and Myanmar?
- 2,747, with Americas (WHO region) ahead.
- How many years of comparable data are there for Americas (WHO region) and Myanmar?
- 17 years are reported by both, from 2008 to 2024.
- How do Americas (WHO region) and Myanmar rank globally for cases started on mdr-tb treatment?
- Americas (WHO region) ranks 11th and Myanmar ranks 13th of 11 groups.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Cases started on MDR-TB treatment. Statizoid refreshes it automatically from the source and publishes the full history for both places.